In an antigen-challenged murine asthma model, lovastatin ameliorates bronchial smooth muscle hyperresponsiveness by reducing RhoA-mediated signaling [35], and it also reduces the expression of geranylgeranyltransferase I in bronchial smooth muscle [36]. Here, RHOA is linked to asthma.